$ABT

AI Analysis

Generated on May 11, 2026

AI Score
72/ 100
Hold$ABT

Abbott Laboratories

$ABTNYSEHealthcareMega-Cap

Abbott discovers, develops, manufactures, and sells health care products including diagnostics, medical devices, nutritionals, and branded generics.

Market Cap
$195.0B
Revenue (TTM)
$41.0B
+5.0%
Net Income (TTM)
$6.5B
+10.0%
EPS (TTM)
$3.72
P/E Ratio
28.0
Dividend Yield
1.8%
52-Week Range
$100-$128
Beta
0.72
Dimension Scores
Fundamental
74
Technical
66
Sentiment
70
Risk / Reward
74
Momentum
65
FundTechSentRiskMome
Financial Health
Profitability
79strong
Growth
68moderate
Liquidity
82strong
Solvency
76strong
Efficiency
72strong

Valuation, technical analysis, investment thesis, risk assessment and more for $ABT

Free · No credit card required

Disclaimer: AI-generated analysis for educational purposes only. Not financial advice. Always consult a qualified financial advisor.

Explore more

Analyze any stock with AI

Get a structured equity research report covering fundamentals, technicals, sentiment, risk, and investment thesis — in about 60 seconds.